Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N V Dimitrov

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Lancet (London, England)|June 22, 1999
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trialB Fisher, J Dignam, N Wolmark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18B Fisher, A Brown, E Mamounas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracilB Fisher, J Dignam, E P Mamounas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Effect of preoperative chemotherapy on the outcome of women with operable breast cancerB Fisher, J Bryant, N Wolmark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23B Fisher, S Anderson, E Tan-Chiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2023
Effect of preoperative chemotherapy on the outcome of women with operable breast cancerB Fisher, J Bryant, N Wolmark, et al.
American Journal of Ophthalmology|April 29, 1998
Long-term tamoxifen citrate use and potential ocular toxicityM B Gorin, R Day, J P Costantino, et al.
Journal of the National Cancer Institute|March 4, 2000
Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02N Wolmark, H S Wieand, D M Hyams, et al.
Journal of the National Cancer Institute|November 6, 1996
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumorsB Fisher, J Dignam, J Bryant, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Lancet (London, England)|June 22, 1999
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trialB Fisher, J Dignam, N Wolmark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18B Fisher, A Brown, E Mamounas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracilB Fisher, J Dignam, E P Mamounas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Effect of preoperative chemotherapy on the outcome of women with operable breast cancerB Fisher, J Bryant, N Wolmark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23B Fisher, S Anderson, E Tan-Chiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2023
Effect of preoperative chemotherapy on the outcome of women with operable breast cancerB Fisher, J Bryant, N Wolmark, et al.
American Journal of Ophthalmology|April 29, 1998
Long-term tamoxifen citrate use and potential ocular toxicityM B Gorin, R Day, J P Costantino, et al.
Journal of the National Cancer Institute|March 4, 2000
Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02N Wolmark, H S Wieand, D M Hyams, et al.
Journal of the National Cancer Institute|November 6, 1996
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumorsB Fisher, J Dignam, J Bryant, et al.
Pageof 5